News Search Results
Jul 29, 2025, 20:43 ET Bedah Ortopedi Presisi di Asia: Memenuhi Kebutuhan Regional Lewat Kolaborasi Akademik bersama MOA dan Aclub
TAIPEI, 30 Juli 2025 /PRNewswire/ -- Malaysian Orthopedic Association (MOA), Aclub Taiwan, dan A Plus Biotechnology Corporation Limited akan menggelar konferensi ilmiah tingkat tinggi pada 3 Agustus 2025 di Sunway Medical Centre, Kuala
More news about: A PLUS BIOTECHNOLOGY CORPORATION LIMITED
Jul 29, 2025, 15:38 ET GLOBO Language Solutions Honored as Silver Stevie® Award Winner for Technology Breakthrough of the Year − Artificial Intelligence
Technology Breakthrough of the Year, and more, in a variety of industry groupings including Advertising, Marketing, and PR, Aerospace Technology, Biotechnology, Business Technology, Healthcare Technology, among others. Last month, GLOBO announced offering its first healthcare-optimized AI interpreter
More news about: GLOBO Language Solutions, LLC
Jul 29, 2025, 13:43 ET Rapid Expansion and Innovation Drive $36 Billion Global Point-of-Care Diagnostics Market, Says New Kalorama Report
InformationKalorama Information, part of Science and Medicine Group, is a leading publisher of independent market research in medical diagnostics, biotechnology, and life sciences. Our reports help global healthcare organizations, investors, and innovators make informed decisions with confidence.
More news about: Kalorama Information
Jul 29, 2025, 10:30 ET Cell Therapy Market to Reach USD 29.5 Billion by 2032, Growing at 21.5% CAGR | SkyQuest Technology Consulting
21.5% from 2025 to 2032, the market is expected to reach USD 29.5 Billion by the end of 2032. Growing investments in biotechnology R&D, rising awareness regarding benefits of cell therapies, and increasing healthcare expenditure are also supporting cell therapy demand.
More news about: SkyQuest Technology
Jul 29, 2025, 10:19 ET INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Fortrea Holdings
from buy to hold. Among other things, the Jefferies Report cited perceived weaknesses in the Company's business model as a CRO amid pressure on biotechnology funding and suggested that the cost savings Fortrea expects to achieve by exiting the TSAs are "not as material as [o]ne [m]ight think," stating
More news about: Faruqi & Faruqi, LLP
Jul 29, 2025, 10:13 ET Optical Measuring Machine Market Experiences High Growth with the Rise in Demand for Precision Across Industries | USD 4.63 billion at 7.3% CAGR by 2031
consulting research services. We specialize in industries such as semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact
More news about: The Insight Partners
Jul 29, 2025, 10:08 ET Cellipont Bioservices and CellVax Therapeutics Expand Partnership to Advance cGMP Manufacturing of Personalized Immunotherapy FK-GI101 for GI Cancers
leading cell therapy Contract Development and Manufacturing Organization (CDMO) and CellVax Therapeutics Inc., a privately held clinical-stage biotechnology company focused on individualized cell-based immunotherapies, today announced a partnership expansion upon prior work on FK-PC101 - currently in
More news about: Cellipont Bioservices
Jul 29, 2025, 10:00 ET ADLM announces 2025 Top Corporate Supporter Award recipients and thanks them for their vital backing
personally deliver the awards to representatives from each of the following organizations: Siemens HealthineersAbbottAnbio BiotechnologyRoche Diagnostics CorporationDanaherBD Integrated Diagnostic SystemsSysmex AmericaThermo Fisher ScientificbioMerieuxWerfenQuidelOrthoDiasorinBio-Rad
More news about: Association for Diagnostics & Laboratory Medicine (ADLM)
Jul 29, 2025, 09:26 ET 180 Life Sciences Announce an Upsized $425 Million Private Placement to Establish an Ether Treasury Reserve Led by Consortium of Digital Asset Leaders to Launch ETHZilla
should give careful consideration to these risks and uncertainties. About 180 Life Sciences The Company is an innovative biotechnology company that has been evolving its business towards software enabled gaming and entertainment. In addition to its existing biotech assets, 180 Life
More news about: 180 Life Sciences Corp.
Jul 29, 2025, 09:00 ET Winners in Second Annual Stevie® Awards for Technology Excellence Announced
TechnologyAgricultural TechnologyArchitectural TechnologyArtificial IntelligenceAssistive TechnologyBiotechnologyBusiness TechnologyCommunication TechnologyEducational TechnologyEnergy TechnologyEntertainment TechnologyFinancial
More news about: The Stevie Awards
Jul 29, 2025, 09:00 ET Winners in Second Annual Stevie® Awards for Technology Excellence Announced
TechnologyAgricultural TechnologyArchitectural TechnologyArtificial IntelligenceAssistive TechnologyBiotechnologyBusiness TechnologyCommunication TechnologyEducational TechnologyEnergy TechnologyEntertainment TechnologyFinancial
More news about: The Stevie Awards
Jul 29, 2025, 09:00 ET Nektar Therapeutics Receives Fast Track Designation for Rezpegaldesleukin for the Treatment of Severe-to-Very Severe Alopecia Areata
medical need for novel, more effective therapies for patients. About Nektar Therapeutics Nektar Therapeutics is a clinical-stage biotechnology company focused on developing treatments that address the underlying immunological dysfunction in autoimmune and chronic inflammatory diseases.
More news about: Nektar Therapeutics
Jul 29, 2025, 08:30 ET Curis to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on August 5, 2025
Mass., July 29, 2025 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced that the Company
More news about: Curis, Inc.
Jul 29, 2025, 08:30 ET Transforming Patient Recruitment: AI and Digital Strategies to Engage the Unreachable 95%, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Jul 29, 2025, 08:30 ET Beyond Diagnosis: The Real-World Impact of AVISE Testing on Lupus, Rheumatoid Arthritis, and Autoimmune Disease Care, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Jul 29, 2025, 08:30 ET Oncolytics Biotech® to Engage FDA for Potential Registration-Enabled Study in First-Line Pancreatic Cancer with Goal to Launch Trial Activities by Year-End
and next steps will be provided following regulatory feedback. About Oncolytics Biotech Inc. Oncolytics is a clinical-stage biotechnology company developing pelareorep, an intravenously delivered immunotherapeutic agent. Pelareorep has demonstrated promising results in two randomized
More news about: Oncolytics Biotech® Inc.
Jul 29, 2025, 08:17 ET At 31.4% CAGR, Urban Air Mobility Market is expected to reach USD 4.41 billion by 2031 | The Insight Partners
consulting research services. We specialize in industries such as semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact
More news about: The Insight Partners
Jul 29, 2025, 08:05 ET Rigel Announces Conference Call and Webcast to Report Second Quarter 2025 Financial Results and Business Update
replay for 90 days after the call via the Rigel website. About RigelRigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders
More news about: Rigel Pharmaceuticals, Inc.
Jul 29, 2025, 08:03 ET NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Join Fireside Chat at BTIG Virtual Biotech Conference July 29 - 30, 2025
Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", or the "Company"), today announced that its CEO and Chairman will join a fireside chat at BTIG Virtual Biotechnology Conference on July 29 – 30, 2025.
More news about: NRx Pharmaceuticals, Inc.
Jul 29, 2025, 08:00 ET Kyowa Kirin Announces Abstract Presentation at the European Academy of Dermatology and Venereology (EADV) Congress
life-changing value. As a Japan-based Global Specialty Pharmaceutical Company, we have invested in drug discovery and biotechnology innovation for more than 70 years and are currently working to engineer the next generation of antibodies and cell and gene therapies with the potential
More news about: Kyowa Kirin
Jul 29, 2025, 08:00 ET Kyowa Kirin Announces Abstract Presentation at the European Academy of Dermatology and Venereology (EADV) Congress
life-changing value. As a Japan-based Global Specialty Pharmaceutical Company, we have invested in drug discovery and biotechnology innovation for more than 70 years and are currently working to engineer the next generation of antibodies and cell and gene therapies with the potential
More news about: Kyowa Kirin
Jul 29, 2025, 08:00 ET Avant Technologies and Ainnova Tech Advance Clinical Trial Protocol Following FDA Feedback
solutions in healthcare using artificial intelligence and biotechnologies. With a focus on pushing the boundaries of what is possible in AI and biotechnology, Avant serves a diverse range of industries, driving progress and efficiency through state-of-the-art technology. More information about
More news about: Avant Technologies Inc.
Jul 29, 2025, 08:00 ET Tampa General is the Top-Ranked Hospital in the Tampa Bay Region for the 10th Year in a Row, According to U.S. News & World Report
Tampa Medical & Research District, an ever-growing hub of clinical care, academics, research and biotechnology in and around downtown Tampa, cementing the region's reputation as a global destination for exceptional care.
More news about: Tampa General Hospital
Jul 29, 2025, 07:35 ET Virax Biolabs Appoints Iain Miller, PhD as Independent Director to Accelerate Commercial Strategy
July 29, 2025 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases, today announced the appointment of Iain
More news about: Virax BioLabs Group Limited
Jul 29, 2025, 06:45 ET Lilly's Jaypirca (pirtobrutinib), the first and only approved non-covalent (reversible) BTK inhibitor, met its primary endpoint in a head-to-head Phase 3 trial versus Imbruvica (ibrutinib) in CLL/SLL
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company